Skip to main content

RM55 RM55 (Sunitinib Malate 37.5 mg)

Pill with imprint RM55 RM55 is Yellow, Capsule-shape and has been identified as Sunitinib Malate 37.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.

Sunitinib is used in the treatment of gastrointestinal stromal tumor; renal cell carcinoma; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RM55 RM55

Sunitinib Malate

Imprint
RM55 RM55
Strength
37.5 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
63304-0093
Inactive Ingredients
croscarmellose sodium, magnesium stearate, mannitol, povidone k30, ferric oxide yellow, titanium dioxide, ferrosoferric oxide, potassium hydroxide, shellac, gelatin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "RM55 RM55"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.